Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review

Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) and predominantly causes kidney and pulmonary injuries. Subarachnoid hemorrhage, a life-threatening manifestation of the central nervous system (CNS), rarely occurs in pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical rheumatology 2022-10, Vol.41 (10), p.3227-3235
Hauptverfasser: Xie, Jingjing, Jia, Ertao, Wang, Suli, Yu, Ye, Li, Zhiling, Zhang, Jianyong, Li, Jia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3235
container_issue 10
container_start_page 3227
container_title Clinical rheumatology
container_volume 41
creator Xie, Jingjing
Jia, Ertao
Wang, Suli
Yu, Ye
Li, Zhiling
Zhang, Jianyong
Li, Jia
description Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) and predominantly causes kidney and pulmonary injuries. Subarachnoid hemorrhage, a life-threatening manifestation of the central nervous system (CNS), rarely occurs in patients with ANCA-associated vasculitis (AAV). We report the case of a young man with spontaneous SAH recurrence and active nephritis. The patient was treated with a glucocorticoid pulse and intravenous cyclophosphamide (CTX) in combination with decreasing cerebral perfusion pressure and analgesic therapy. All the patients’ symptoms except the proteinuria resolved. We reviewed the clinical characteristics of 34 previously reported cases of SAH with AAV, comprising six cases of MPA, eight cases of granulomatosis with polyangiitis (GPA), and 19 cases of eosinophilic granulomatosis with polyangiitis (EGPA), and one case of unclassified AAV. All the cases showed features of active vasculitis. Concomitant nephritis and peripheral neuropathy were found in the MPA and EGPA cases with SAH, respectively. Renal and pulmonary manifestations were predominant in the patients with GPA and SAH. Ten patients had aneurysmal abnormalities, and six patients had cardiac abnormalities. Thirty-one patients were treated with glucocorticoids, and 18 patients received concurrent immunosuppressants. Patients with SAH had a mortality rate of 38.2%. The presence of cerebrovascular events or cardiac involvement in patients with AAV and SAH is associated with increased mortality of 64.3%. Our study indicates that SAH should be cautioned as a disease occurring in patients with AAV. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients with SAH.
doi_str_mv 10.1007/s10067-022-06163-6
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9485077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2715614462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-451ade3462ea448bf6b38a79620f0d4b36f137ca87e482af795acdf58d8ab0433</originalsourceid><addsrcrecordid>eNp9UcuKFTEUDKI416s_4EICbty0Jp10Hi4EGXzBgCC6DqfT6b4Z0kmbdI_Mxm831zuOj4WbBHKq6qSqEHpMyXNKiHxR6ilkQ9q2IYIK1og7aEc5443WXN9FOyIlaRjV6gw9KOWSENIqTe-jM9YJTYTQO_T9kwuwFB8nXLYeMthDTH7ABzennA8wOQwFA7bBR28h4BmiH11ZYfUpYh_x7G1OxabFW7ykcA1x8n715eWRBcXh7JaUVwxxwMGvLsO65ePrlXffHqJ7I4TiHt3ce_Tl7ZvP5--bi4_vPpy_vmgsl2RteEdhcIyL1gHnqh9FzxRILVoykoH3TIyUSQtKOq5aGKXuwA5jpwYFPeGM7dGrk-6y9bMbrItrhmCW7GfI1yaBN39Poj-YKV0ZzVVXY6wCz24Ecvq6Vf9m9sW6ECC6tBXTCtkJwnSNf4-e_gO9TFuO1Z5pJe0E5dVHRbUn1DG9kt14-xlKzLFec6rX1HrNz3qNqKQnf9q4pfzqswLYCVDqKE4u_979H9kfCa-z4w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2715614462</pqid></control><display><type>article</type><title>Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review</title><source>SpringerLink Journals</source><creator>Xie, Jingjing ; Jia, Ertao ; Wang, Suli ; Yu, Ye ; Li, Zhiling ; Zhang, Jianyong ; Li, Jia</creator><creatorcontrib>Xie, Jingjing ; Jia, Ertao ; Wang, Suli ; Yu, Ye ; Li, Zhiling ; Zhang, Jianyong ; Li, Jia</creatorcontrib><description>Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) and predominantly causes kidney and pulmonary injuries. Subarachnoid hemorrhage, a life-threatening manifestation of the central nervous system (CNS), rarely occurs in patients with ANCA-associated vasculitis (AAV). We report the case of a young man with spontaneous SAH recurrence and active nephritis. The patient was treated with a glucocorticoid pulse and intravenous cyclophosphamide (CTX) in combination with decreasing cerebral perfusion pressure and analgesic therapy. All the patients’ symptoms except the proteinuria resolved. We reviewed the clinical characteristics of 34 previously reported cases of SAH with AAV, comprising six cases of MPA, eight cases of granulomatosis with polyangiitis (GPA), and 19 cases of eosinophilic granulomatosis with polyangiitis (EGPA), and one case of unclassified AAV. All the cases showed features of active vasculitis. Concomitant nephritis and peripheral neuropathy were found in the MPA and EGPA cases with SAH, respectively. Renal and pulmonary manifestations were predominant in the patients with GPA and SAH. Ten patients had aneurysmal abnormalities, and six patients had cardiac abnormalities. Thirty-one patients were treated with glucocorticoids, and 18 patients received concurrent immunosuppressants. Patients with SAH had a mortality rate of 38.2%. The presence of cerebrovascular events or cardiac involvement in patients with AAV and SAH is associated with increased mortality of 64.3%. Our study indicates that SAH should be cautioned as a disease occurring in patients with AAV. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients with SAH.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-022-06163-6</identifier><identifier>PMID: 35690669</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Analgesics ; Aneurysm ; Antineutrophil cytoplasmic antibodies ; Case Based Review ; Case reports ; Central nervous system ; Cyclophosphamide ; Glucocorticoids ; Granulomatosis ; Immunosuppressive agents ; Intravenous administration ; Leukocytes (eosinophilic) ; Leukocytes (neutrophilic) ; Literature reviews ; Medicine ; Medicine &amp; Public Health ; Mortality ; Nephritis ; Patients ; Peripheral neuropathy ; Proteinuria ; Rheumatology ; Subarachnoid hemorrhage ; Vasculitis</subject><ispartof>Clinical rheumatology, 2022-10, Vol.41 (10), p.3227-3235</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-451ade3462ea448bf6b38a79620f0d4b36f137ca87e482af795acdf58d8ab0433</citedby><cites>FETCH-LOGICAL-c470t-451ade3462ea448bf6b38a79620f0d4b36f137ca87e482af795acdf58d8ab0433</cites><orcidid>0000-0002-0692-3071 ; 0000-0002-3606-3949 ; 0000-0002-2078-4629 ; 0000-0002-6216-5252 ; 0000-0002-1877-2776 ; 0000-0002-0513-1689 ; 0000-0001-6579-7397</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10067-022-06163-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10067-022-06163-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35690669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xie, Jingjing</creatorcontrib><creatorcontrib>Jia, Ertao</creatorcontrib><creatorcontrib>Wang, Suli</creatorcontrib><creatorcontrib>Yu, Ye</creatorcontrib><creatorcontrib>Li, Zhiling</creatorcontrib><creatorcontrib>Zhang, Jianyong</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><title>Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><description>Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) and predominantly causes kidney and pulmonary injuries. Subarachnoid hemorrhage, a life-threatening manifestation of the central nervous system (CNS), rarely occurs in patients with ANCA-associated vasculitis (AAV). We report the case of a young man with spontaneous SAH recurrence and active nephritis. The patient was treated with a glucocorticoid pulse and intravenous cyclophosphamide (CTX) in combination with decreasing cerebral perfusion pressure and analgesic therapy. All the patients’ symptoms except the proteinuria resolved. We reviewed the clinical characteristics of 34 previously reported cases of SAH with AAV, comprising six cases of MPA, eight cases of granulomatosis with polyangiitis (GPA), and 19 cases of eosinophilic granulomatosis with polyangiitis (EGPA), and one case of unclassified AAV. All the cases showed features of active vasculitis. Concomitant nephritis and peripheral neuropathy were found in the MPA and EGPA cases with SAH, respectively. Renal and pulmonary manifestations were predominant in the patients with GPA and SAH. Ten patients had aneurysmal abnormalities, and six patients had cardiac abnormalities. Thirty-one patients were treated with glucocorticoids, and 18 patients received concurrent immunosuppressants. Patients with SAH had a mortality rate of 38.2%. The presence of cerebrovascular events or cardiac involvement in patients with AAV and SAH is associated with increased mortality of 64.3%. Our study indicates that SAH should be cautioned as a disease occurring in patients with AAV. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients with SAH.</description><subject>Analgesics</subject><subject>Aneurysm</subject><subject>Antineutrophil cytoplasmic antibodies</subject><subject>Case Based Review</subject><subject>Case reports</subject><subject>Central nervous system</subject><subject>Cyclophosphamide</subject><subject>Glucocorticoids</subject><subject>Granulomatosis</subject><subject>Immunosuppressive agents</subject><subject>Intravenous administration</subject><subject>Leukocytes (eosinophilic)</subject><subject>Leukocytes (neutrophilic)</subject><subject>Literature reviews</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mortality</subject><subject>Nephritis</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><subject>Proteinuria</subject><subject>Rheumatology</subject><subject>Subarachnoid hemorrhage</subject><subject>Vasculitis</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9UcuKFTEUDKI416s_4EICbty0Jp10Hi4EGXzBgCC6DqfT6b4Z0kmbdI_Mxm831zuOj4WbBHKq6qSqEHpMyXNKiHxR6ilkQ9q2IYIK1og7aEc5443WXN9FOyIlaRjV6gw9KOWSENIqTe-jM9YJTYTQO_T9kwuwFB8nXLYeMthDTH7ABzennA8wOQwFA7bBR28h4BmiH11ZYfUpYh_x7G1OxabFW7ykcA1x8n715eWRBcXh7JaUVwxxwMGvLsO65ePrlXffHqJ7I4TiHt3ce_Tl7ZvP5--bi4_vPpy_vmgsl2RteEdhcIyL1gHnqh9FzxRILVoykoH3TIyUSQtKOq5aGKXuwA5jpwYFPeGM7dGrk-6y9bMbrItrhmCW7GfI1yaBN39Poj-YKV0ZzVVXY6wCz24Ecvq6Vf9m9sW6ECC6tBXTCtkJwnSNf4-e_gO9TFuO1Z5pJe0E5dVHRbUn1DG9kt14-xlKzLFec6rX1HrNz3qNqKQnf9q4pfzqswLYCVDqKE4u_979H9kfCa-z4w</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Xie, Jingjing</creator><creator>Jia, Ertao</creator><creator>Wang, Suli</creator><creator>Yu, Ye</creator><creator>Li, Zhiling</creator><creator>Zhang, Jianyong</creator><creator>Li, Jia</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0692-3071</orcidid><orcidid>https://orcid.org/0000-0002-3606-3949</orcidid><orcidid>https://orcid.org/0000-0002-2078-4629</orcidid><orcidid>https://orcid.org/0000-0002-6216-5252</orcidid><orcidid>https://orcid.org/0000-0002-1877-2776</orcidid><orcidid>https://orcid.org/0000-0002-0513-1689</orcidid><orcidid>https://orcid.org/0000-0001-6579-7397</orcidid></search><sort><creationdate>20221001</creationdate><title>Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review</title><author>Xie, Jingjing ; Jia, Ertao ; Wang, Suli ; Yu, Ye ; Li, Zhiling ; Zhang, Jianyong ; Li, Jia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-451ade3462ea448bf6b38a79620f0d4b36f137ca87e482af795acdf58d8ab0433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analgesics</topic><topic>Aneurysm</topic><topic>Antineutrophil cytoplasmic antibodies</topic><topic>Case Based Review</topic><topic>Case reports</topic><topic>Central nervous system</topic><topic>Cyclophosphamide</topic><topic>Glucocorticoids</topic><topic>Granulomatosis</topic><topic>Immunosuppressive agents</topic><topic>Intravenous administration</topic><topic>Leukocytes (eosinophilic)</topic><topic>Leukocytes (neutrophilic)</topic><topic>Literature reviews</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mortality</topic><topic>Nephritis</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><topic>Proteinuria</topic><topic>Rheumatology</topic><topic>Subarachnoid hemorrhage</topic><topic>Vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Jingjing</creatorcontrib><creatorcontrib>Jia, Ertao</creatorcontrib><creatorcontrib>Wang, Suli</creatorcontrib><creatorcontrib>Yu, Ye</creatorcontrib><creatorcontrib>Li, Zhiling</creatorcontrib><creatorcontrib>Zhang, Jianyong</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Jingjing</au><au>Jia, Ertao</au><au>Wang, Suli</au><au>Yu, Ye</au><au>Li, Zhiling</au><au>Zhang, Jianyong</au><au>Li, Jia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2022-10-01</date><risdate>2022</risdate><volume>41</volume><issue>10</issue><spage>3227</spage><epage>3235</epage><pages>3227-3235</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) and predominantly causes kidney and pulmonary injuries. Subarachnoid hemorrhage, a life-threatening manifestation of the central nervous system (CNS), rarely occurs in patients with ANCA-associated vasculitis (AAV). We report the case of a young man with spontaneous SAH recurrence and active nephritis. The patient was treated with a glucocorticoid pulse and intravenous cyclophosphamide (CTX) in combination with decreasing cerebral perfusion pressure and analgesic therapy. All the patients’ symptoms except the proteinuria resolved. We reviewed the clinical characteristics of 34 previously reported cases of SAH with AAV, comprising six cases of MPA, eight cases of granulomatosis with polyangiitis (GPA), and 19 cases of eosinophilic granulomatosis with polyangiitis (EGPA), and one case of unclassified AAV. All the cases showed features of active vasculitis. Concomitant nephritis and peripheral neuropathy were found in the MPA and EGPA cases with SAH, respectively. Renal and pulmonary manifestations were predominant in the patients with GPA and SAH. Ten patients had aneurysmal abnormalities, and six patients had cardiac abnormalities. Thirty-one patients were treated with glucocorticoids, and 18 patients received concurrent immunosuppressants. Patients with SAH had a mortality rate of 38.2%. The presence of cerebrovascular events or cardiac involvement in patients with AAV and SAH is associated with increased mortality of 64.3%. Our study indicates that SAH should be cautioned as a disease occurring in patients with AAV. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients with SAH.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35690669</pmid><doi>10.1007/s10067-022-06163-6</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0692-3071</orcidid><orcidid>https://orcid.org/0000-0002-3606-3949</orcidid><orcidid>https://orcid.org/0000-0002-2078-4629</orcidid><orcidid>https://orcid.org/0000-0002-6216-5252</orcidid><orcidid>https://orcid.org/0000-0002-1877-2776</orcidid><orcidid>https://orcid.org/0000-0002-0513-1689</orcidid><orcidid>https://orcid.org/0000-0001-6579-7397</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0770-3198
ispartof Clinical rheumatology, 2022-10, Vol.41 (10), p.3227-3235
issn 0770-3198
1434-9949
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9485077
source SpringerLink Journals
subjects Analgesics
Aneurysm
Antineutrophil cytoplasmic antibodies
Case Based Review
Case reports
Central nervous system
Cyclophosphamide
Glucocorticoids
Granulomatosis
Immunosuppressive agents
Intravenous administration
Leukocytes (eosinophilic)
Leukocytes (neutrophilic)
Literature reviews
Medicine
Medicine & Public Health
Mortality
Nephritis
Patients
Peripheral neuropathy
Proteinuria
Rheumatology
Subarachnoid hemorrhage
Vasculitis
title Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A52%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relapsing%20subarachnoid%20hemorrhage%20as%20a%20clinical%20manifestation%20in%20microscopic%20polyangiitis:%20a%20case%20report%20and%20literature%20review&rft.jtitle=Clinical%20rheumatology&rft.au=Xie,%20Jingjing&rft.date=2022-10-01&rft.volume=41&rft.issue=10&rft.spage=3227&rft.epage=3235&rft.pages=3227-3235&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-022-06163-6&rft_dat=%3Cproquest_pubme%3E2715614462%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2715614462&rft_id=info:pmid/35690669&rfr_iscdi=true